These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 24140721)
21. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage. Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451 [TBL] [Abstract][Full Text] [Related]
22. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide. Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316 [TBL] [Abstract][Full Text] [Related]
23. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery. Kowapradit J; Apirakaramwong A; Ngawhirunpat T; Rojanarata T; Sajomsang W; Opanasopit P Eur J Pharm Sci; 2012 Sep; 47(2):359-66. PubMed ID: 22771544 [TBL] [Abstract][Full Text] [Related]
24. Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery. Chen M; Li XR; Zhou YX; Yang KW; Chen XW; Deng Q; Liu Y; Ren LJ Peptides; 2009 Jul; 30(7):1288-95. PubMed ID: 19540427 [TBL] [Abstract][Full Text] [Related]
25. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix. Guggi D; Kast CE; Bernkop-Schnürch A Pharm Res; 2003 Dec; 20(12):1989-94. PubMed ID: 14725364 [TBL] [Abstract][Full Text] [Related]
26. Preparation and Evaluation of Enteric-Coated Chitosan Derivative-Based Microparticles Loaded with Salmon Calcitonin as an Oral Delivery System. Onishi H; Tokuyasu A Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649146 [TBL] [Abstract][Full Text] [Related]
27. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin. Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061 [TBL] [Abstract][Full Text] [Related]
29. Preactivated thiomers for vaginal drug delivery vehicles. Friedl HE; Dünnhaupt S; Waldner C; Bernkop-Schnürch A Biomaterials; 2013 Oct; 34(32):7811-8. PubMed ID: 23886732 [TBL] [Abstract][Full Text] [Related]
30. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery. Sinsuebpol C; Chatchawalsaisin J; Kulvanich P Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397 [TBL] [Abstract][Full Text] [Related]
31. Examination of Effective Buccal Absorption of Salmon Calcitonin Using Cell-Penetrating Peptide-Conjugated Liposomal Drug Delivery System. Keum T; Noh G; Seo JE; Bashyal S; Sohn DH; Lee S Int J Nanomedicine; 2022; 17():697-710. PubMed ID: 35210769 [TBL] [Abstract][Full Text] [Related]
32. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery. Millotti G; Laffleur F; Perera G; Vigl C; Pickl K; Sinner F; Bernkop-Schnürch A J Pharm Sci; 2014 Oct; 103(10):3165-70. PubMed ID: 25139279 [TBL] [Abstract][Full Text] [Related]
33. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin. Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976 [TBL] [Abstract][Full Text] [Related]
34. Visualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestine. Thongborisute J; Takeuchi H; Yamamoto H; Kawashima Y J Liposome Res; 2006; 16(2):127-41. PubMed ID: 16753967 [TBL] [Abstract][Full Text] [Related]
35. Transmucosal macromolecular drug delivery. Prego C; García M; Torres D; Alonso MJ J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901 [TBL] [Abstract][Full Text] [Related]
36. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of functional characteristics of preactivated thiolated chitosan as potential therapeutic agent for dry mouth syndrome. Laffleur F; Fischer A; Schmutzler M; Hintzen F; Bernkop-Schnürch A Acta Biomater; 2015 Jul; 21():123-31. PubMed ID: 25900442 [TBL] [Abstract][Full Text] [Related]
38. Protection of dopamine towards autoxidation reaction by encapsulation into non-coated- or chitosan- or thiolated chitosan-coated-liposomes. Trapani A; Mandracchia D; Tripodo G; Cometa S; Cellamare S; De Giglio E; Klepetsanis P; Antimisiaris SG Colloids Surf B Biointerfaces; 2018 Oct; 170():11-19. PubMed ID: 29859476 [TBL] [Abstract][Full Text] [Related]
39. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles. Umerska A; Corrigan OI; Tajber L Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Prego C; Fabre M; Torres D; Alonso MJ Pharm Res; 2006 Mar; 23(3):549-56. PubMed ID: 16525861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]